(VIANEWS) – Shares of 10x Genomics (NASDAQ: TXG) rose 9.08% to $45.51 at 11:04 EST on Thursday, after five sequential sessions in a row of gains. NASDAQ is jumping 0.75% to $11,135.87, following the last session’s downward trend. This seems, at the moment, a somewhat up trend exchanging session today.

10x Genomics’s last close was $41.72, 80.04% below its 52-week high of $208.99.


Today’s last reported volume for 10x Genomics is 207913 which is 86.4% below its average volume of 1529267.

10x Genomics’s Sales

10x Genomics’s sales growth is 78.1% for the present quarter and 33.2% for the next. The company’s growth estimates for the present quarter and the next is 70.8% and 97.2%, respectively.

10x Genomics’s Revenue

Year-on-year quarterly revenue growth grew by 170%, now sitting on 405.7M for the twelve trailing months.


10x Genomics’s last week, last month’s, and last quarter’s current intraday variation average was a positive 3.92%, a negative 1.29%, and a positive 4.78%, respectively.

10x Genomics’s highest amplitude of average volatility was 3.92% (last week), 5.59% (last month), and 4.78% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

10x Genomics’s stock is considered to be oversold (<=20).

10x Genomics’s Stock Yearly Top and Bottom Value

10x Genomics’s stock is valued at $45.51 at 11:04 EST, way under its 52-week low of $128.15.

10x Genomics’s Moving Average

10x Genomics’s worth is way below its 50-day moving average of $155.93 and way below its 200-day moving average of $170.12.

More news about 10x Genomics (TXG).


Please enter your comment!
Please enter your name here